首页> 外文期刊>Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association >We Cannot Say Biologic Therapy Is Not Useful in Patients With Short-Bowel Syndrome From Resections Related to Crohn's Disease, nor Can We Conclude They Are of Value Reply

【24h】

We Cannot Say Biologic Therapy Is Not Useful in Patients With Short-Bowel Syndrome From Resections Related to Crohn's Disease, nor Can We Conclude They Are of Value Reply

机译：我们不能说生物学治疗在与克罗恩病相关的切除术中的短肠综合征患者中没有有用，我们也不能得出重视答复

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association》 |2018年第5期|共1页
作者
Limketkai Berkeley N.; Colombel Jean-Frederic;
展开▼
作者单位

Stanford Univ Div Gastroenterol &

Hepatol Sch Med Stanford CA 94305 USA;

Icahn Sch Med Mt Sinai Div Gastroenterol &

Hepatol New York NY 10029 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. 右上肺叶切除术中肺支气管和血管不同的解剖顺序与肺癌患者的手术可行性和术后恢复相关 [J] . Hao-Ran Zhai, Hai-Yan Tu, Xu-Chao Zhang, 癌症（英文版） . 2018,第004期
2. We Cannot Say Biologic Therapy Is Not Useful in Patients With Short-Bowel Syndrome From Resections Related to Crohn's Disease, nor Can We Conclude They Are of Value Reply [J] . Limketkai Berkeley N., Colombel Jean-Frederic Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2018,第5期

机译：我们不能说生物学治疗在与克罗恩病相关的切除术中的短肠综合征患者中没有有用，我们也不能得出重视答复
3. Letter: biologics treatment in Crohn's disease and risk of bowel resection—what about the patients who stop anti‐ TNF TNF therapy? Authors’ reply [J] . Eberhardson M., S?derling J. K., Olén O. Alimentary pharmacology & therapeutics. . 2018,第1期

机译：信：克罗恩病的生物学治疗和肠切除症的风险 - 止动抗TNF治疗的患者呢？作者的回复
4. Letter: Faecal calprotectin and lactoferrin - Accurate biomarkers in post-operative Crohn's disease - Authors' reply: Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - Authors' reply [J] . JonesG.R., KennedyN.A., LeesC.W., Alimentary pharmacology & therapeutics. . 2014,第3期

机译：信件：粪便钙卫蛋白和乳铁蛋白-克罗恩病术后的准确生物标志物-作者的答复：信件：生物疗法可有效预防克罗恩病术后复发-作者的答复
5. Fluorescence endoscopic imaging study of anastomotic recurrence of Crohn's disease after right ileocolonic resection [C] . Serge R. Mordon, INSERM, Lille Cedex, Optical Biopsies . 1995

机译：右回结肠切除术后克罗恩病吻合口复发的荧光内镜成像研究
6. Quantifying disease progression trajectory and investigating the impact of early initiation of biologic therapy in patients with Crohn's disease using the Lemann index of cumulative bowel damage. [D] . Panchal, Hina J. 2017

机译：使用累积肠损伤的Lemann指数量化疾病进展轨迹，并研究早期开始生物治疗对克罗恩病患者的影响。
7. Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study [O] . Takayuki Yamamoto, Antonino Spinelli, Yasuo Suzuki, 2016

机译：回肠结肠切除术后克罗恩病并发症的危险因素主要集中于术前免疫抑制和生物疗法的影响：一项回顾性国际多中心研究
8. Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy? Authors’ reply [O] . M. Eberhardson, J. K. Söderling, O. Olén 2017

机译：字母：生物学治疗克罗恩病的疾病和肠切除风险 - 止动TNF治疗的患者呢？作者的回复

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号